SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Read more breaking news

 

 
News in brief

LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft

06-Feb-2017
Last updated on 06-Feb-2017 at 17:28 GMT2017-02-06T17:28:13Z

LabCorp in talks to buy the CRO PPD for $8Bn

Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report , a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance  in 2015.

PPD offers contract research services from inhalation products to biologics , for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired  Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related products

Related suppliers

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...